Literature DB >> 22345646

A 17q12 allele is associated with altered NK cell subsets and function.

Zongqi Xia1, Qingquan Liu, Christoph T Berger, Brendan T Keenan, Anna Kaliszewska, Patrick C Cheney, Gyan P Srivastava, Irene Wood Castillo, Philip L De Jager, Galit Alter.   

Abstract

NK cells play an important role in innate immunity. A previous genome-wide association study demonstrated an association between a 17q12 allele (rs9916629(C)) and lower frequency of CD3(-)CD56(+) NK cells in peripheral blood. We performed an analysis that not only replicates the original result of the genome-wide association study (p = 0.036) but also defines the specific cell subpopulations and functions that are modulated by the rs9916629 polymorphism in a cohort of 96 healthy adult subjects using targeted multiparameter flow cytometric profiling of NK cell phenotypes and functions. We found that rs9916629(C) is associated with alterations in specific NK cell subsets, including lower frequency of predominantly cytotoxic CD56(dim) NK cells (p = 0.011), higher frequency of predominantly regulatory CD56(bright) NK cells (p = 0.019), and a higher proportion of NK cells expressing the inhibitory NKG2A receptor (p = 0.0002). Functionally, rs9916629(C) is associated with decreased secretion of macrophage inflammatory protein-1β by NK cells in the context of Ab-dependent cell-mediated cytotoxicity (p = 0.039) and increased degranulation in response to MHC class I-deficient B cells (p = 0.017). Transcriptional profiling of NK cells suggests that rs9916629 influences the expression of transcription factors such as TBX21, which has a role in NK cell differentiation, offering a possible mechanism for the phenotypic and functional differences between the different alleles. The rs9916629(C) allele therefore has a validated effect on the proportion of NK cells in peripheral blood and skews NK cells toward a specific phenotypic and functional profile, potentially influencing the impact that these innate immune cells have on infection and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22345646      PMCID: PMC9444297          DOI: 10.4049/jimmunol.1102775

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.426


  36 in total

1.  A novel transcription factor, T-bet, directs Th1 lineage commitment.

Authors:  S J Szabo; S T Kim; G L Costa; X Zhang; C G Fathman; L H Glimcher
Journal:  Cell       Date:  2000-03-17       Impact factor: 41.582

2.  Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.

Authors:  P V Sivakumar; A Gunturi; M Salcedo; J D Schatzle; W C Lai; Z Kurepa; L Pitcher; M S Seaman; F A Lemonnier; M Bennett; J Forman; V Kumar
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

Review 3.  Natural killer cells, viruses and cancer.

Authors:  A Cerwenka; L L Lanier
Journal:  Nat Rev Immunol       Date:  2001-10       Impact factor: 53.106

4.  T-bet is essential for the progression of experimental autoimmune encephalomyelitis.

Authors:  Narender Nath; Ratna Prasad; Shailendra Giri; Avtar K Singh; Inderjit Singh
Journal:  Immunology       Date:  2006-07       Impact factor: 7.397

Review 5.  The T-box transcription factor T-bet in immunity and autoimmunity.

Authors:  Stanford L Peng
Journal:  Cell Mol Immunol       Date:  2006-04       Impact factor: 11.530

6.  CD107a as a functional marker for the identification of natural killer cell activity.

Authors:  Galit Alter; Jessica M Malenfant; Marcus Altfeld
Journal:  J Immunol Methods       Date:  2004-11       Impact factor: 2.303

7.  Cytometric profiling in multiple sclerosis uncovers patient population structure and a reduction of CD8low cells.

Authors:  Philip L De Jager; Elizabeth Rossin; Saumyadipta Pyne; Pablo Tamayo; Linda Ottoboni; Vissia Viglietta; Mira Weiner; Dulce Soler; Elena Izmailova; Lauren Faron-Yowe; Carmeline O'Brien; Sam Freeman; Susana Granados; Alex Parker; Ronenn Roubenoff; Jill P Mesirov; Samia J Khoury; David A Hafler; Howard L Weiner
Journal:  Brain       Date:  2008-06-21       Impact factor: 13.501

8.  Increased NKG2A found in cytotoxic natural killer subset in HIV-1 patients with advanced clinical status.

Authors:  Ruijun Zhang; Jianqing Xu; Kunxue Hong; Lin Yuan; Hong Peng; Haili Tang; Pengfei Ma; Yuanzhi Zhang; Hui Xing; Yuhua Ruan; Yiming Shao
Journal:  AIDS       Date:  2007-12       Impact factor: 4.177

9.  Quantitative trait loci for CD4:CD8 lymphocyte ratio are associated with risk of type 1 diabetes and HIV-1 immune control.

Authors:  Manuel A R Ferreira; Massimo Mangino; Chanson J Brumme; Zhen Zhen Zhao; Sarah E Medland; Margaret J Wright; Dale R Nyholt; Scott Gordon; Megan Campbell; Brian P McEvoy; Anjali Henders; David M Evans; Jerry S Lanchbury; Florencia Pereyra; Bruce D Walker; David W Haas; Nicole Soranzo; Tim D Spector; Paul I W de Bakker; Ian H Frazer; Grant W Montgomery; Nicholas G Martin
Journal:  Am J Hum Genet       Date:  2009-12-31       Impact factor: 11.025

Review 10.  Human natural killer cells.

Authors:  Michael A Caligiuri
Journal:  Blood       Date:  2008-08-01       Impact factor: 22.113

View more
  11 in total

1.  Clinical relevance and functional consequences of the TNFRSF1A multiple sclerosis locus.

Authors:  Linda Ottoboni; Irene Y Frohlich; Michelle Lee; Brian C Healy; Brendan T Keenan; Zongqi Xia; Tanuja Chitnis; Charles R Guttmann; Samia J Khoury; Howard L Weiner; David A Hafler; Philip L De Jager
Journal:  Neurology       Date:  2013-10-30       Impact factor: 9.910

2.  A molecular signature of preclinical rheumatoid arthritis triggered by dysregulated PTPN22.

Authors:  Hui-Hsin Chang; Guang-Yaw Liu; Nishant Dwivedi; Bo Sun; Yuko Okamoto; Jennifer D Kinslow; Kevin D Deane; M Kristen Demoruelle; Jill M Norris; Paul R Thompson; Jeffrey A Sparks; Deepak A Rao; Elizabeth W Karlson; Hui-Chih Hung; V Michael Holers; I-Cheng Ho
Journal:  JCI Insight       Date:  2016-10-20

Review 3.  Coordinating GWAS results with gene expression in a systems immunologic paradigm in autoimmunity.

Authors:  Barbara E Stranger; Phillip L De Jager
Journal:  Curr Opin Immunol       Date:  2012-10-03       Impact factor: 7.486

Review 4.  An inflection point in gene discovery efforts for neurodegenerative diseases: from syndromic diagnoses toward endophenotypes and the epigenome.

Authors:  Philip L De Jager; David A Bennett
Journal:  JAMA Neurol       Date:  2013-06       Impact factor: 18.302

5.  Landscape of X chromosome inactivation across human tissues.

Authors:  Taru Tukiainen; Alexandra-Chloé Villani; Angela Yen; Manuel A Rivas; Jamie L Marshall; Rahul Satija; Matt Aguirre; Laura Gauthier; Mark Fleharty; Andrew Kirby; Beryl B Cummings; Stephane E Castel; Konrad J Karczewski; François Aguet; Andrea Byrnes; Tuuli Lappalainen; Aviv Regev; Kristin G Ardlie; Nir Hacohen; Daniel G MacArthur
Journal:  Nature       Date:  2017-10-11       Impact factor: 49.962

Review 6.  Autoimmunity in 2012.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

7.  Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors.

Authors:  Alexandra-Chloé Villani; Rahul Satija; Gary Reynolds; Siranush Sarkizova; Karthik Shekhar; James Fletcher; Morgane Griesbeck; Andrew Butler; Shiwei Zheng; Suzan Lazo; Laura Jardine; David Dixon; Emily Stephenson; Emil Nilsson; Ida Grundberg; David McDonald; Andrew Filby; Weibo Li; Philip L De Jager; Orit Rozenblatt-Rosen; Andrew A Lane; Muzlifah Haniffa; Aviv Regev; Nir Hacohen
Journal:  Science       Date:  2017-04-21       Impact factor: 47.728

8.  Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.

Authors:  Adrian Cortes; Johanna Hadler; Jenny P Pointon; Philip C Robinson; Tugce Karaderi; Paul Leo; Katie Cremin; Karena Pryce; Jessica Harris; Seunghun Lee; Kyung Bin Joo; Seung-Cheol Shim; Michael Weisman; Michael Ward; Xiaodong Zhou; Henri-Jean Garchon; Gilles Chiocchia; Johannes Nossent; Benedicte A Lie; Øystein Førre; Jaakko Tuomilehto; Kari Laiho; Lei Jiang; Yu Liu; Xin Wu; Linda A Bradbury; Dirk Elewaut; Ruben Burgos-Vargas; Simon Stebbings; Louise Appleton; Claire Farrah; Jonathan Lau; Tony J Kenna; Nigil Haroon; Manuel A Ferreira; Jian Yang; Juan Mulero; Jose Luis Fernandez-Sueiro; Miguel A Gonzalez-Gay; Carlos Lopez-Larrea; Panos Deloukas; Peter Donnelly; Paul Bowness; Karl Gafney; Hill Gaston; Dafna D Gladman; Proton Rahman; Walter P Maksymowych; Huji Xu; J Bart A Crusius; Irene E van der Horst-Bruinsma; Chung-Tei Chou; Raphael Valle-Oñate; Consuelo Romero-Sánchez; Inger Myrnes Hansen; Fernando M Pimentel-Santos; Robert D Inman; Vibeke Videm; Javier Martin; Maxime Breban; John D Reveille; David M Evans; Tae-Hwan Kim; Bryan Paul Wordsworth; Matthew A Brown
Journal:  Nat Genet       Date:  2013-06-09       Impact factor: 38.330

9.  Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma.

Authors:  Mariafausta Fischietti; Frank Eckerdt; Gavin T Blyth; Ahmet D Arslan; William M Mati; Chidera V Oku; Ricardo E Perez; Catalina Lee-Chang; Ewa M Kosciuczuk; Diana Saleiro; Elspeth M Beauchamp; Maciej S Lesniak; Daniela Verzella; Leyu Sun; Eleanor N Fish; Guang-Yu Yang; Wenan Qiang; Leonidas C Platanias
Journal:  Oncogene       Date:  2021-04-12       Impact factor: 9.867

10.  Targeting individual cells by barcode in pooled sequence libraries.

Authors:  Navpreet Ranu; Alexandra-Chloé Villani; Nir Hacohen; Paul C Blainey
Journal:  Nucleic Acids Res       Date:  2019-01-10       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.